Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope Abstract: Syncope as an initial presentation of pulmonary embolism occurs in 10% of patients. We compared clinical and instrumental parameters in patients with syncope as the presenting symptom of pulmonary embolism and in patients with documented pulmonary embolism without syncope. Seventy patients with the diagnosis of pulmonary embolism and apparently stable clinical conditions were evaluated. They were divided in two groups: 10 patients with syncope as the presenting symptom of pulmonary embolism (group 1) and 60 patients without syncope (group 2). Patients with syncope showed a more pronounced tendency to present with main pulmonary artery embolus than patients without syncope (contingency coef cientˆ0.301, p < 0.04; one-tailed). However, despite the evidence that patients with syncope have signi cant reductions in systolic and=or diastolic blood pressure, shock was not observed in any patient. In no case was thrombolytic treatment given and all patients received standard anticoagulation with unfractioned heparin and oral anticoagulant. We suggest that syncope in the setting of non-massive pulmonary embolism may be due to vaso-vagal mechanism that can lead to a reduction of arterial blood pressure when central artery thrombosis is involved.
Introduction
Pulmonary embolism (PE) is a potentially fatal disorder. The range of clinical presentation is very wide: clinical symptoms range from haemodynamic instability to clinically silent disease. 1 In 90% of cases, suspicion of PE is raised by clinical symptoms of dyspnoea, chest pain or syncope either singly or in combination. In a classic series, dyspnoea, tachypnoea, or chest pain were present in 97% of patients with PE. 2 On the other hand, syncope is a common chief complaint of patients in the emergency department accounting for approximately 3% of visits. 3, 4 There are many categories of syncope according to the underlying cause: cardiac causes (arrhythmic and non-arrhythmic), seizure disorder, vaso-vagal, and orthostatic causes, medications and other infrequent causes such as stroke or transient ischaemic attack. Aetiology remains unknown in more than a third of patients, despite clinical and instrumental evaluation. Syncope as an initial presentation of PE occurs in 10% of patients. 5 Syncope in the setting of PE can be explained by three mechanisms. Massive PE can cause acute right ventricular failure, impaired left ventricular lling, and reduced cerebral ow perfusion. A second mechanism implicated in the pathogenesis of syncope in PE is haemodynamically unstable tachydysrhythmias and bradydysrhythmias. PE can also cause syncope in patients with pre-existing left bundle branch block: the development of acute right bundle branch block due to PE in these individuals can lead to complete atrioventricular block and syncope.
M oreover, PE can trigger a vaso-vagal re ex and lead to syncope on a neurogenic basis. In 1867, von Bezold introduced the theory of depressor re exes originating in the heart. Later descriptions by Jarisch led to the term Bezold-Jarisch re ex to describe an arc originating in cardiac sensory receptors located principallyin theleft ventricle,particularly along the infero-posterior wall, but also along the base of the right ventricle. 6, 7 Stimulation of these receptors by mechanical stretch or chemical agents triggers impulses along non-myelinated vagal afferents with increased parasympathetic and decreased sympathetic activity. The consequence is bradycardia with vasodilation, and hypotension.
It is important to identify PE as a cause of syncope because prompt identi cation and appropriate treatment may be life-saving.
In the present study we compared clinical and instrumental parameters in patients with PE and syncope and in patients with documented PE without syncope. suspected PE underwent a standardized evaluation in the Emergency Department and were then admitted to our Internal M edicine Unit. F irst level evaluation included: complete history, physical and neurological examination, a laboratory evaluation including D -dimer test, chest X-ray lm, 12-lead electrocardiogram (ECG ) and blood gas analysis. Each patient received a pre-test probability evaluation according to the scoring criteria proposed by Wells et al. 8 Criteria include suspected deep vein thrombosis (DVT) (3.0 points), an alternative diagnosis less likely than PE (3.0 points), heart rate > 100 beats=min (1.5 points), recent immobilization or surgery (1.5 points), previous DVT=PE (1.5 points), haemoptysis (1.0 point) and malignancy (1.0 point). Patients were considered low probability if the score was lower than 2.0, moderate if the score was 2.0 to 6.0, and high if the score was over 6.0.
A complete two-dimensional and D oppler echocardiogram was performed in all study subjects within 24 h from the diagnosis of PE. Studies were performed by a single experienced operator who was unaware of clinical or haemodynamic details of the patients. The presence of RV dilatation and systolic dysfunction, and abnormal septal motion and deviation were visually assessed. Continuous-wave D oppler recording of tricuspid regurgitation signal was obtained from the para-sternal, apical, and subcostal windows. D oppler-derived systolic pulmonary artery pressure was then calculated from the peak-tricuspid regurgitant velocity using the Bernoulli equation. 9 Patients with low pre-test probability and a negative Ddimer were ruled out for PE and no further investigations were performed. Patients with moderate and high clinical probability and=or positive D -dimer values underwent instrumental evaluation between 30 min and 2 h after admission to the Emergency Department. PE was documented in all patients by a multi-detector spiral computed tomography scan (sCTs) showing partial or complete lling defects in pulmonary circulation. In a subgroup of patients, a lung perfusion scan was performed prior to a sCTs. These patients had clinical contraindications to performing contrast medium CT scanning in the Emergency Department (transitory acute renal failure due to dehydration, apparent risk of allergic reaction to contrast media). The presence of DVT was assessed either by means of lower limb ultrasonography or by computed tomography 'run-off' imaging of the lower limbs. A sCTs was performed with a multi-slice instrument (Light Speed, G E, Wisconsin, USA). PE was classi ed as central (involving main through to segmental branches) and peripheral (sub-segmental).
All patients were divided in two subgroups: (1) patients with PE and syncope as a presenting symptom and (2) patients with PE without syncope. Syncope was de ned as a sudden, transient loss of consciousness with the inability to maintain postural tone and spontaneous recovery. All data were collected in a database.
Statistical analysis
Unless otherwise expressed, differences between groups were evaluated by the non-parametric Wilcoxon-Mann-Whitney U-test.
A p-value < 0.05 was considered signi cant. The Expected number of cases in contingency Table 4 were obtained according to the standard computational formula employed in any cross-tabulation (contingency table) and=or chi-square analysis.
Results
A total of 70 patients with the diagnosis of PE were evaluated; 10 (14.3% ) patients ( ve females, mean age 69 10.98 years) with documented PE had syncope in association with their episode of PE. Table 1 compares the clinical assessment of patients with and without syncope. Transient hypotension (systolic BP < 90mmHg) was documented in three patients (30% ) with syncope at the time of admission to our emergency room. N o major bradyarrhythmias or tachyarrhythmias were recorded in patients at the time of admission or during hospitalization. No patients presented in cardiac arrest. Table 2 shows clinical and instrumental data of patients with syncope in comparison with patients with PE who did not have syncope; patients with syncope are characterized by a statistically signi cant reduction in systolic and diastolic blood pressure. However, no patient had shock (as de ned by systolic blood pressure < 90 mmHg and clinical evidence of inadequate organ perfusion). Arterial blood gases, while breathing room air, were not signi cantly different between the two groups of patients. Two out of 10 patients with PE and syncope had echocardiographic signs of right atrial or ventricular enlargement. In patients with PE without syncope, echocardiographic signs of atrial or ventricular enlargement were found in six out of 60 patients. Table 3 shows the pre-test clinical score according to Wells in patients with PE, with and without syncope as the presenting symptom. Statistical analysis revealed no differences between patients with and without syncope in the probability of presenting with a PE (Uˆ221, zˆÿ 1.00, p > 0.32).
The diagnosis of PE was documented with a sCTs in 10 patients with syncope (100% ). In eight patients, a sCTs documented main pulmonary artery embolus and in two patients lobar artery embolus was found. In no case were segmental and sub-segmental emboli found alone. Nine patients with syncope and 39 patients without syncope showed bilateral involvement of PE. Statistical analysis revealed no statistically signi cant correlation between bilateral involvement and syncope (p > 0.22). D eep vein thrombo-embolism was documented by compressive ultrasonography in three patients with syncope and with computed tomography (run-off) in one patient.
All patients received standard anticoagulation with unfractioned heparins at standard doses and then with oral anticoagulants.
Discussion
PE is a frequent cause of death. Prevalence of PE has been estimated to be approximately 630 000 cases per year in the USA. It has been estimated that PE may be directly responsible for up to 100 000 deaths and a contributing cause in another 100 000 cases. N onetheless, the diagnosis of PE remains dif cult. The classic triad of pleuritic chest pain, dyspnoea and haemoptysis is rare in large studies on PE. 10 Karwinski and Svendsen found that 81% of PE discovered at autopsy are unsuspected before death. 11 The overall mortality rate for untreated PE ranges from 20% to 30% . Syncope, in contrast to PE, is relatively easy to detect and relatively common: in fact, approximately 3% of emergency department visits are due to syncope, although it may be dif cult to assign a speci c aetiology to this symptom. In one large prospective study, 42% of 433 patients with syncope were discharged with a diagnosis of unknown origin despite extensive evaluation, and a review of numerous studies indicated a 47% failure rate in assigning a cause to syncope. 12 Syncope as an initial presentation of PE occurs in about 10% of patients. Among our patients with PE, 14.3% had syncope as the main symptom, but in this patient group with PE and syncope, nine experienced dyspnoea and only one had chest pain and dyspnoea as simultaneous symptoms. However, clinical suspicion of PE in patients presenting with an isolated syncopal spell may be not intuitively simple. In fact, in our series, none of the patients with syncope had a high probability clinical score for PE.
In our study, a de nitive diagnosis was performed mainly with sCTs. This test has some advantages for diagnosing PE. It is particularly useful in the emergency department because it is minimally invasive, produces a direct image of the thrombi in the pulmonary circulation, and can help identify other disorders that may be responsible for the patient's symptoms. [13] [14] [15] The lling defect, with partial or total vessel occlusion, may be classi ed as central or peripheral. When the ndings from sCTs are compared with angiography for embolism involving central arteries (main artery through to segmental branches), a pooled analysis of large series reported high sensivity (94% ), speci city (94% ) and positive predictive value (93% ). 15, 16 The overall sensitivity (central plus peripheral embolism) for PE of sCTs is thought to be approximately 85% . The low sensivity (50-60% ) reported in some series has been attributed to the inconsistent ability of sCTs to detect sub-segmental PE. 17, 18 The frequency of sub-segmental PE is reported to be 6% . 19, 20 In our study we observed six patients with sub-segmental emboli in the group of patients without syncope (10% ). Analysis of spiral computed tomography ndings in the two groups of patients analysed in this study (see Table 4 ) indicates that: (a) patients with syncope had a more pronounced tendency to present main pulmonary artery thrombosis than patients without syncope, whereas patients without syncope showed a greater tendency to present lobar, segmental, and sub-segmental artery thrombosis than patients with syncope; (b) in no case did patients with PE presenting with syncope have a peripheral artery involvement alone. To date, no data are present in literature concerning the relationship between clinical presentation and sCTs ndings for PE. This nding may suggest that syncope in the setting of the PE is due to acute right ventricular failure.
Previous studies have correlated haemodynamic and angiographic ndings, indicating that acute right ventricular failure can occur when 50% -75% or more of the pulmonary vascular bed is occluded. [21] [22] [23] Marked hypotension and shock may be a consequence with high mortality. It has recently been proposed that the cardiac enzymes troponin I (cTnI) and troponin T (cTnT) and brain natriuretic peptide (BNP) may be a useful prognostic factor in patients with PE. 24 Giannitsis et al demonstrated that elevated cTn is associated with prolonged hypotension, cardiogenic shock, need for inotropic support or resuscitation and death in hospital. 25 In addition, BNP is a marker for left ventricular dysfunction which may also increase in response to acute right ventricular overload. In fact, Tulevski et al measured BPN levels in 16 consecutive patients with acute PE and in 12 healthy volunteers. Plasma BPN levels were higher in patients than in controls and were signi cantly higher in ve patients with right ventricular dysfunction compared with 11 patients with normal right ventricular function. 26 We cannot rule out that syncope in our patients with PE may have been due to right ventricular afterload as a consequence of pulmonary vascular obstruction determining right ventricular failure and a decrease of left ventricular pre-load. H owever, in our study, echocardiographic signs of acute right ventricular failure or decreased cardiac output were rarely found. These data are in contrast with previously published register data suggesting that 40% of patients presenting with PE have right ventricular hypokinesis. 27 It must be considered that in our study echocardiographic examination was carried out within 24 h from the diagnosis of PE. G iven that PE is a 'dynamic disease', a limitation of our observation is that the time interval between syncope and echocardiographic assessment may have been suf ciently long to reduce the differences in echocardiographic ndings between patients with or without syncope. On the other hand, involvement of the main and lobar pulmonary arteries can trigger a vaso-vagal re ex that leads to syncope on a neurogenic basis. The Bezold-Jarisch re ex has been described in infero-posterior myocardial ischaemia and infarction, coronary catheterization, exert ional syncope with aortic stenosis, and vaso-vagal syncope induced by tilt table testing. In acute PE, the hyperadrenergic state results in increased contractility of an under lled left ventricle. This, in turn, may stimulate Bezold-Jarisch ventricular receptors and increase vagal impulses, causing sinus and atrioventricular nodal slowing, peripheral vasodilatation and syncope.
In our study, hypotension was signi cantly more common in patients with syncope compared with those without syncope. However, shock was not observed in our cases and no patient received thrombolytic treatment. Patients with right ventricular dysfunction were not treated with thrombolytic agents as they were haemodynamically stable. This is in accord with recent recommendations from the British Thoracic Society and the European Cardiac Society. 28, 29 Data from a large registry of patients with PE and right ventricular dysfunction suggest that thrombolysis may offer some advantages. H owever, controlled randomized trials de nitively demonstrating that thrombolysis reduces mortality in these patients are lacking. 30 It cannot be excluded that patients may have suffered signi cant haemodynamic compromise early at the onset of PE with subsequent improvement due to fragmentation of the embolus. In fact, in our patients, death was mainly related to underlying disease, and in no case was it related to haemodynamic failure.
F inally, we were unfortunately unable to document either blood pressure or heart rate at the time of syncope. This data may have added further strength to the proposed association between syncope in PE and vaso-vagal causes.
Conclusion
Although our observation is based on a selected subset of lower-risk patients, we suggest that syncope in the setting of PE may be due to a vaso-vagal mechanism that can lead to a reduction of arterial blood pressure when central artery thrombosis is involved. In our study, patients with syncope as a presenting symptom did not show a more serious clinical picture than patients without syncope, but prompt diagnosis and adequate treatment are mandatory. Table 3 were analysed in a 2 4 contingency table. (Contingency coef cientˆ0.301, p < 0.04; one-tailed.) Expected frequencies are reported in parentheses.
In fact, mortality was low in both groups and no signicant differences were found. It must be noted, however, that syncope is frequently associated with main pulmonary artery embolism; the prognosis in these cases is largely dependent on a timely diagnosis and treatment.
